CMRX NASDAQ
Chimerix, Inc.
1W: +0.2%
1M: +0.8%
3M: +140.6%
1Y: +844.7%
3Y: +82.1%
5Y: +454.6%
$8.54
Last traded 2025-04-21 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2022-09-26
Earliest Filing
2025-03-05
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named CMRX in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals plc | acquirer | Target of a merger and tender offer by Jazz Pharmaceuticals via Pinetree Acquisition Sub, Inc. | 2025-03-05 | View |
| EBS Emergent BioSolutions Inc. | acquirer | Seller of exclusive worldwide rights to brincidofovir, including TEMBEXA, acquired by Emergent BioSolutions Inc. | 2022-09-26 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR